Quick Links

Parkinson's news

MNI scientist receives $1.5M grant for Parkinson's/ALS research

CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research CQDM and Brain Canada are proud to announce the funding of two new multi-disciplinary and multi-institutional research projects under the second edition of their Focus on Brain strategic initiative. The partners will award a total of $3M to two research teams to develop cutting-edge tools, technologies and platforms designed to accelerate the discovery of new drugs for brain and nervous system disorders.

Published on : 02 Feb 2017

Researchers open new path of discovery in Parkinson’s disease

A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at McGill University have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease. Using both cellular and mouse models, the team has shown that proteins produced by the two genes, known as PINK1 and Parkin, are required to prevent cells from being detected and attacked by the immune system.

Published on : 27 Jun 2016

Parkinson’s disease: A new tool for diagnosis

The results of their study, published in the journal Movement Disorders, could also have a major impact on the quality of research on Parkinson’s disease.

Published on : 13 Nov 2015

Skin cells for research into Parkinson's

Millions of Canadians are affected by diseases of the brain such as ALS, Parkinson’s and brain tumours, for which there are limited treatments and no cures. By 2020, neurological conditions will become the leading cause of death and disability.

Category :
Published on : 02 Apr 2015

April - Parkinson’s Disease Awareness Month

The Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, is at the forefront of Parkinson’s research and clinical care. Parkinson’s patients are seen at The Neuro’s Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson’s disease. The Neuro to introduce experimental drug treatment

Category :
Published on : 02 Apr 2015

April - Parkinson’s Disease Awareness Month

The Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, is at the forefront of Parkinson’s research and clinical care. Parkinson’s patients are seen at The Neuro’s Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson’s disease.   New Rapid-Access Clinic at The Neuro reduces wait time

Category :
Published on : 31 Mar 2014

Quality control of mitochondria as a defense against disease

Scientists from the Montreal Neurological Institute and Hospital in Canada have discovered that two genes linked to hereditary Parkinson’s disease are involved in the early-stage quality control of mitochondria. The protective mechanism, which is reported in The EMBO Journal, removes damaged proteins that arise from oxidative stress from mitochondria. 

Category :
Published on : 21 Jan 2014

Unleashing the watchdog protein

Research opens door to new drug therapies for Parkinson’s disease McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson’s disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The Neuro, and  Dr. Kalle Gehring  in the Department of Biochemistry at the Faculty of Medicine, have discovered the three-dimensional structure of the protein Parkin.

Category :
Published on : 09 May 2013

April is Parkinson’s Disease Awareness Month

What is Parkinson’s Disease? Parkinson’s disease is a neurological condition related to the death of specific brain cells that produce dopamine, a chemical needed for brain cells to control muscular movement. In Parkinson’s disease, dopamine-producing cells stop functioning for reasons still unknown.

Category :
Published on : 04 Apr 2013

Clinician-scientists at The Neuro receive funding for Parkinson’s and HIV research

November 27, 2012 - Clinician-scientists take a unique, integrated approach that is essential to advancing science and medicine. Problems encountered in the clinic inspire research and new findings from the labs are directly applied to patients’ needs. The integrated model is a hallmark of the Montreal Neurological Institute and Hospital – The Neuro, at McGill University and the MUHC and is now being replicated worldwide.

Category :
Published on : 05 Feb 2013

Scientists discover gene behind rare disorders

International study with researchers at The Neuro reveals links with other neurodegenerative diseases MONTREAL, October 9, 2012  - Scientists at the Montreal Neurological Institute and Hospital – The Neuro,  McGill University working with a team at Oxford University have uncovered the genetic defect underlying a group of rare genetic disorders.  Using a new technique that has revolutionized genetic studies, the teams determined that mutations in the RMND1 gene were responsible for severe neurodegenerative disorders, in two infants, ultimately leading to thei

Category :
Published on : 09 Oct 2012